Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response

Introduction Nipah virus is a high-consequence pathogen that causes sporadic outbreaks with high mortality, and there are currently no vaccines or therapeutics available for Nipah. Vaccine development against Nipah faces challenges due to its current epidemiology with limited outbreak sizes, which i...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sol Kim, Hyolim Kang, Laura Skrip, Sushant Sahastrabuddhe, Ausraful Islam, Sung-Mok Jung, Juan F. Vesga, Akira Endo, W. John Edmunds, Kaja Abbas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2025-12-01
Edice:	Expert Review of Vaccines
Témata:	Alternative regulatory pathway Nipah virus Henipavirus nipahense pandemic preparedness vaccine efficacy trials vaccine licensure
On-line přístup:	https://www.tandfonline.com/doi/10.1080/14760584.2025.2476523
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!